The proposed $36 billion acquisition has received all but one of 28 required regulatory clearances. Antitrust review by the European Commission is ongoing.
Consumers must be able to rely upon and trust allergen claims, not second guess or wonder whether a product that says “may contain” or makes soft claims like “nut-free” are safe to consume.
OMI Industries' Laura Haupert recently spoke to Cannabis Products about the odor challenges cannabis producers face and strategies for overcoming them.